Sept 1 (Reuters) – Ultragenyx Pharmaceutical Inc. : * ULTRAGENYX ANNOUNCES THE PUBLICATION OF A SUCCESSFUL 96-WEEK RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH CROSSOVER TREATMENT OF GENGLYCOS™ (ALSO
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 19 (Reuters) - TRI.N: * THOMSON REUTERS CORP - CONTINUES TO EXPECT GLOBAL PRINT…
Norway targets 'harmful' social media, games with under-16 ban
OSLO, Oct 19 (Reuters) - Norway's planned social media ban for children will include provisions…
Nvidia-backed Nscale, Anthropic in talks for new $45 billion AI cloud deal, source says
Oct 19 (Reuters) - Nscale is in talks to sell AI computing power to Claude…
